ELAN
Elanco Animal Health Incorporated · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +11.8% ·
share flow +3.4% ·
net new positions +10.5%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 104.77K | $2.05M | n/a | −2 |
| Q2 2026 | 128 | +5 | 426.57M | $10.50B | +12 | −8 |
| Q1 2026 | 127 | -2 | 403.59M | $9.65B | +6 | −9 |
| Q4 2025 | 128 | +1 | 433.50M | $9.81B | +4 | −2 |
| Q3 2025 | 20 | -1 | 348.71M | $7.02B | n/a | −2 |
| Q2 2025 | 19 | +2 | 313.01M | $4.47B | +3 | −1 |
| Q1 2025 | 14 | -2 | 167.03M | $1.75B | +1 | −3 |
| Q4 2024 | 16 | -2 | 168.00M | $2.03B | n/a | −2 |
| Q3 2024 | 17 | +1 | 175.40M | $2.58B | +1 | n/a |
| Q2 2024 | 16 | n/a | 207.32M | $2.99B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 82.90M | 0.0% | $1.18B | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 64.88M | n/a | $926.53M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 3 | PRIMECAP Management ✦ | 51.77M | +3.1% | $739.23M | 0.6% | ▲ Add | 5 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 47.83M | n/a | $682.97M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 5 | BlackRock ✦ (passive) | 23.07M | n/a | $329.46M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 6 | Citadel Advisors ✦ | 13.70M | +99.5% | $195.65M | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | State Street Global Advisors ✦ (passive) | 9.13M | -1.4% | $130.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 8.07M | -3.4% | $115.24M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 3.84M | New | $54.78M | 0.1% | New | 1 | SEC ↗ |
| 10 | Capital World Investors ✦ | 2.00M | New | $28.56M | 0.0% | New | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.97M | New | $28.13M | 0.1% | New | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.42M | -63.5% | $20.25M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 13 | Norges Bank ✦ (passive) | 875.51K | -73.5% | $12.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 395.20K | -1.7% | $5.64M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 355.27K | -30.3% | $5.07M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 16 | Arrowstreet Capital ✦ | 310.38K | +2006.9% | $4.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 215.09K | -43.9% | $3.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 167.14K | -68.1% | $2.39M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 19 | Gotham Asset Management ✦ | 124.99K | -64.8% | $1.78M | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $54.78M | 0.1% |
| Capital World Investors | $28.56M | 0.0% |
| Point72 Asset Management | $28.13M | 0.1% |
Exited
| Renaissance Technologies | $348,012 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 512 holders, 543.55M shares, $11.98B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 40.00K sh @ 23.40 · $935,920
Officer · GC AND CORP SEC · 4.00K sh @ 23.58 · $94,273
Director · 5.00K sh @ 21.82 · $109,100
Director · 10.00K sh @ 23.68 · $236,850
Officer · EVP and CFO · 4.20K sh @ 23.08 · $96,926
Open-market sales (S)
Officer · 4.35K sh · $100,050
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology